Victory Capital Management Inc Oyster Point Pharma, Inc. Transaction History

Victory Capital Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 09, 2020	SELL	$17.83 - $29.12 $187,696 - $306,546	-10,527 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$27.86 - $35.93 $15,991 - $20,623	574 Added 5.77%	10,527 $304,000
Q1 2020 May 04, 2020	SELL	$23.65 - $40.96 $1,111 - $1,925	-47 Reduced 0.47%	9,953 $348,000
Q4 2019 Feb 06, 2020	SELL	$13.55 - $26.15 $5,663 - $10,930	-418 Reduced 4.01%	10,000 $244,000
Q4 2019 Feb 04, 2020	BUY	$13.55 - $26.15 $141,163 - $272,430	10,418 New	10,418 $328,000

19K

Ticker OYST
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,831,500
Description
Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry ...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.